• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制剂中硅酸盐会降低肠外营养配方中铝的含量。

Low availability of aluminum in formulations for parenteral nutrition containing silicate.

机构信息

Department of Chemistry, Universidade Federal de Santa Maria, Santa Maria, Brazil.

出版信息

JPEN J Parenter Enteral Nutr. 2009 Nov-Dec;33(6):694-701. doi: 10.1177/0148607109333004. Epub 2009 Jul 8.

DOI:10.1177/0148607109333004
PMID:19587384
Abstract

BACKGROUND

Silicate (Si) and aluminum (Al) may be concomitant impurities in solutions for parenteral nutrition (PN). Silicate can bind to Al to form stable hydroxyaluminosilicates (HAS), thus reducing Al availability. This possibility is investigated by heating solutions containing constituents of PN in glass containers to promote the release of Si and Al.

METHODS

The total amount of Si and Al in solution is measured by atomic absorption spectrometry, and the Al not bound to Si is evaluated by reaction with morin.

RESULTS

When the Si:Al molar ratio is >5, no free Al is found in solution. For ratios <5, it is found that the lower the ratio, the higher the free Al fraction. However, in solutions of some amino acids, even with a low Si:Al ratio (<2), the amount of free Al is lower than that found in other solutions. The same tendency is observed among commercial formulations. Although in salt solutions the free fraction of Al reaches almost 100% when the Si concentration is low, in amino acid formulations the free fraction of Al does not surpass 50%. Moreover, even for Si:Al ratios >5, there is a "residual" fraction of free Al in amino acid formulations.

CONCLUSIONS

The concomitant presence of Al and Si in solutions for PN reduces the amount of Al available attributable to the formation of HAS. In amino acid formulations this effect may be slightly reduced given the affinity of certain amino acids for Al. Therefore, amino acids may behave in the same fashion as silicate.

摘要

背景

硅(Si)和铝(Al)可能是肠外营养(PN)溶液中的伴随杂质。硅可以与铝结合形成稳定的羟基铝硅酸盐(HAS),从而降低铝的可用性。通过在玻璃容器中加热含有 PN 成分的溶液来促进 Si 和 Al 的释放,可以研究这种可能性。

方法

通过原子吸收光谱法测量溶液中 Si 和 Al 的总量,并通过与棓酸反应评估与 Si 结合的 Al。

结果

当 Si:Al 摩尔比>5 时,溶液中没有游离 Al。对于比值<5 的情况,发现比值越低,游离 Al 分数越高。然而,在某些氨基酸溶液中,即使 Si:Al 比值较低(<2),游离 Al 的量也低于其他溶液。商业配方中也观察到相同的趋势。尽管在盐溶液中,当 Si 浓度较低时,Al 的游离分数达到近 100%,但在氨基酸配方中,Al 的游离分数不超过 50%。此外,即使 Si:Al 比值>5,氨基酸配方中仍存在游离 Al 的“残余”分数。

结论

PN 溶液中 Al 和 Si 的共存会降低由于 HAS 形成而导致的可用 Al 量。在氨基酸配方中,由于某些氨基酸对 Al 的亲和力,这种影响可能会略有降低。因此,氨基酸的行为可能与硅相似。

相似文献

1
Low availability of aluminum in formulations for parenteral nutrition containing silicate.制剂中硅酸盐会降低肠外营养配方中铝的含量。
JPEN J Parenter Enteral Nutr. 2009 Nov-Dec;33(6):694-701. doi: 10.1177/0148607109333004. Epub 2009 Jul 8.
2
Silicate release from glass for pharmaceutical preparations.用于药物制剂的玻璃中硅酸盐的释放。
Int J Pharm. 2008 May 1;355(1-2):174-83. doi: 10.1016/j.ijpharm.2007.12.025. Epub 2007 Dec 24.
3
Influence of the glass packing on the contamination of pharmaceutical products by aluminium. Part II: amino acids for parenteral nutrition.
J Trace Elem Med Biol. 2001;15(2-3):103-8. doi: 10.1016/S0946-672X(01)80051-1.
4
Effect of OH-/Al3+ and Si/Al molar ratios on the coagulation performance and residual Al speciation during surface water treatment with poly-aluminum-silicate-chloride (PASiC).聚硅酸铝氯(PASiC)处理地表水过程中 OH-/Al3+ 和 Si/Al 摩尔比对混凝性能和残余 Al 形态的影响。
J Hazard Mater. 2011 May 15;189(1-2):203-10. doi: 10.1016/j.jhazmat.2011.02.017. Epub 2011 Feb 15.
5
Interactions of silicate ions with zinc(II) and aluminum(III) in alkaline aqueous solution.碱性水溶液中硅酸根离子与锌(II)和铝(III)的相互作用。
Inorg Chem. 2005 Oct 31;44(22):8023-32. doi: 10.1021/ic050594c.
6
Arsenic release from glass containers by action of intravenous nutrition formulation constituents.
Int J Pharm. 2006 Jun 6;315(1-2):24-9. doi: 10.1016/j.ijpharm.2006.02.008. Epub 2006 Apr 18.
7
Excessive aluminum accumulation in the bones of patients on long-term parenteral nutrition: postmortem analysis by electrothermal atomic absorption spectrometry.长期肠外营养患者骨骼中铝的过度蓄积:电热原子吸收光谱法的尸检分析
JPEN J Parenter Enteral Nutr. 2014 Aug;38(6):728-35. doi: 10.1177/0148607113491981. Epub 2013 Jun 13.
8
Aluminum content of parenteral nutrition in neonates: measured versus calculated levels.新生儿肠外营养中的铝含量:实测值与计算值。
J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):208-11. doi: 10.1097/MPG.0b013e3181aed70b.
9
Aluminum content in intravenous solutions for administration to neonates: role of product preparation and administration methods.静脉输注溶液中铝的含量:产品制备和给药方法的作用。
JPEN J Parenter Enteral Nutr. 2010 May-Jun;34(3):322-8. doi: 10.1177/0148607110362531.
10
Interference of Parenteral Nutrition Components in Silicon-Mediated Protection Against Aluminum Bioaccumulation.肠外营养成分对硅介导的抗铝生物蓄积保护作用的干扰。
Biol Trace Elem Res. 2024 Aug;202(8):3662-3671. doi: 10.1007/s12011-023-03929-0. Epub 2023 Nov 4.

引用本文的文献

1
Interference of Parenteral Nutrition Components in Silicon-Mediated Protection Against Aluminum Bioaccumulation.肠外营养成分对硅介导的抗铝生物蓄积保护作用的干扰。
Biol Trace Elem Res. 2024 Aug;202(8):3662-3671. doi: 10.1007/s12011-023-03929-0. Epub 2023 Nov 4.
2
Aluminum exposure and toxicity in neonates: a practical guide to halt aluminum overload in the prenatal and perinatal periods.新生儿的铝暴露和毒性:在产前和围产期停止铝过载的实用指南。
World J Pediatr. 2014 May;10(2):101-7. doi: 10.1007/s12519-014-0477-x. Epub 2014 May 7.